News
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
PORTLAND, Maine, May 14, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) (the "Company" or "ImmuCell"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2020
PORTLAND, Maine, May 13, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Unaudited Financial Results for First Quarter of 2020
Conference Call Scheduled for Thursday, May 14, 2020 at 9:00 AM ETPORTLAND, Maine, May 07, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
ImmuCell Receives $938,000 in Support under the Paycheck Protection Program
PORTLAND, Maine, April 14, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020
PORTLAND, Maine, April 02, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Refinancing of its Bank Debt
PORTLAND, Maine, March 11, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Correction to its Reported Unaudited Loss Per Share from ($0.06) to ($0.04) for the Quarter Ended December 31, 2019
PORTLAND, Maine, Feb. 19, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2019
PORTLAND, Maine, Feb. 18, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...
ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019
Conference Call Scheduled for Wednesday, February 19, 2020 at 9:00 AM ETPORTLAND, Maine, Feb. 13, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven...
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Year Ended December 31, 2019
PORTLAND, Maine, Jan. 21, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy...